Stanley Druckenmiller's RYTM Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 203,618 shares of Rhythm Pharmaceuticals, Inc. (RYTM) worth $22.61 M, representing 0.43% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Stanley Druckenmiller has initiated a new position in RYTM, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's Rhythm Pharmaceuticals (RYTM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rhythm Pharmaceuticals (RYTM) Trades by Stanley Druckenmiller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +203,618 | New Buy | 203,618 | $111.03 |
Stanley Druckenmiller's Rhythm Pharmaceuticals Investment FAQs
Stanley Druckenmiller first purchased Rhythm Pharmaceuticals, Inc. (RYTM) in Q2 2026, acquiring 203,618 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held Rhythm Pharmaceuticals, Inc. (RYTM) for 1 quarters since Q2 2026.
Stanley Druckenmiller's largest addition to Rhythm Pharmaceuticals, Inc. (RYTM) was in Q2 2026, adding 203,618 shares worth $22.61 M.
According to the latest 13F filing for Q2 2026, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 203,618 shares of Rhythm Pharmaceuticals, Inc. (RYTM), valued at approximately $22.61 M.
As of the Q2 2026 filing, Rhythm Pharmaceuticals, Inc. (RYTM) represents approximately 0.43% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings.
Stanley Druckenmiller's peak holding in Rhythm Pharmaceuticals, Inc. (RYTM) was 203,618 shares, as reported at the end of Q2 2026.